The global artificial intelligence in drug repurposing market stood at USD 1.3 billion in 2025 and is forecast to climb to USD 7.7 billion by 2033, growing at a CAGR of 24.5% between 2026 and 2033. North America leads with 52.9% share, oncology is the top application at 36.7%, and software & platform tools account for 66.6% of spend. Baricitinib was designed as a rheumatoid...